Hae
Aineistot 1-1 / 1
Characterization of Clever-1 expressing extracellular vesicles and their effect on T lymphocyte proliferation
(2021-05-10)
Immune checkpoint inhibitors (ICIs) are the new milestone for the management of advanced solid cancers. Unfortunately, most patients are not responsive to these treatments, since they may develop mechanisms that suppress ...